A skin cancer vaccine developed by researchers at the Dana-Farber Cancer Institute was effective for up to four years, according to a study reported in the journal Nature. The eight patients involved in the study received the NeoVax vaccine about 18 weeks after having tumors removed.
Researchers say skin cancer vaccine effective for 4 years
Sign up for Sigma Xi SmartBrief
News on scientific research and innovation
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.